Troglitazone or ciglitazone or
GW1929 + TRAIL |
Independent |
Lung |
DR5, c-FLIP |
[34] |
15d-PGJ2 + TRAIL |
Independent |
Leukemia, prostate |
DR5 |
[47] |
Troglitazone + TRAIL |
Independent |
Glioblastoma, neuroblastoma |
c-FLIP, survivin, DR5 |
[52] |
Rosiglitazone + TRAIL |
Independent |
Renal, glioma, breast, prostate |
ROS, DR5, c-FLIP |
[49] |
15d-PGJ2 or ciglitazone
or troglitazone or CDDO or CDDO-Me + TRAIL |
Independent |
Prostate, ovarian, colon |
c-FLIP |
[50] |
Troglitazone + TRAIL or troglitazone
+ etoposide or paclitaxel |
Independent |
Glioma |
PTP1B, STAT3, c-FLIP, Bcl-2 |
[53] |
15d-PGJ2 + MK886 |
Dependent |
Lung |
PPARγ, RXRα
|
[54] |
15d-PGJ2 + Indomethacin |
Ciglitazone + MK886 +
13-cis-retinoic acid |
Rosiglitazone + LG100268 or all
transretinoic acid |
Dependent and independent |
Leukemia, lymphoma, myeloma |
Bcl-2, caspase-9 |
[55] |
15d-PGJ2 + LG100268 or
all trans-retinoic acid |
CDDO + LG100268 or all transretinoic
acid |
Rosiglitazone + carboplatin |
Dependent |
Lung, ovarian, colon |
MT1H, MT1X, MTIIA |
[56] |
TZD18 + imatinib |
Independent |
Leukemia |
Bax, NF-κB |
[57, 58] |
RS5444 + paclitaxel |
Dependent |
Thyroid |
p21WAF1/CIP1 |
[59] |
15dPGJ2 + docetaxel |
Independent |
Lung |
Bcl-2, BAD, cyclin D1, p53 |
[60] |